» Articles » PMID: 35469734

Acute Myocardial Infarction Following Hospitalization for Gastrointestinal Bleeding: Incidence, Predictors, Management, and Outcomes

Overview
Journal Am J Med
Specialty General Medicine
Date 2022 Apr 26
PMID 35469734
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Clinical characteristics of patients with acute myocardial infarction after gastrointestinal bleeding are poorly characterized. We sought to evaluate the incidence, management and outcomes of myocardial infarction following hospitalization for gastrointestinal bleeding.

Methods: Patients admitted with a diagnosis of gastrointestinal bleeding with and without subsequent hospital readmissions for acute myocardial infarction within 90 days were identified in the 2014 U.S. Nationwide Readmission Database. Patients with myocardial infarction with and without a recent prior gastrointestinal bleed were compared to determine differences in management and in-hospital outcomes. Logistic regression models were used to estimate odds of invasive management and all-cause in-hospital mortality after covariate adjustment.

Results: A total of 644,622 patients with gastrointestinal bleeding were identified, of which 7523 (1.2%) were readmitted for myocardial infarction within 90 days. Compared to patients with myocardial infarction without recent gastrointestinal bleeding, patients with myocardial infarction within 90 days after gastrointestinal bleeding were older, more likely to be women, have kidney disease, presented with non-ST segment elevation myocarsdial infarction, and were less likely to undergo invasive management of acute myocardial infarction (28% vs 63%, P < .01). Prior gastrointestinal bleeding was associated with higher all-cause in-hospital myocardial infarction mortality (22% vs 9%, P < .01).

Conclusion: In the first 3 months after hospitalization for gastrointestinal bleeding, 1 of every 83 patients was readmitted with acute myocardial infarction. Patients with myocardial infarction after gastrointestinal bleeding were less likely to undergo invasive management and coronary revascularization and had higher mortality than those without recent bleeding.

Citing Articles

Study on Immune-Related Genes and Clinical Validation of Acute Myocardial Infarction Based on Bioinformatics.

Jin S, Wu Z Biochem Genet. 2025; .

PMID: 39820825 DOI: 10.1007/s10528-025-11029-y.


The causal effect of Helicobacter pylori infection on coronary heart disease is mediated by the body mass index: a Mendelian randomization study.

Li B, Zhang Y, Zheng Y, Cai H Sci Rep. 2024; 14(1):1688.

PMID: 38243041 PMC: 10798959. DOI: 10.1038/s41598-024-51701-8.

References
1.
Mehran R, Baber U, Sharma S, Cohen D, Angiolillo D, Briguori C . Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med. 2019; 381(21):2032-2042. DOI: 10.1056/NEJMoa1908419. View

2.
Sung J, Lau J, Ching J, Wu J, Lee Y, Chiu P . Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009; 152(1):1-9. DOI: 10.7326/0003-4819-152-1-201001050-00179. View

3.
Moukarbel G, Signorovitch J, Pfeffer M, McMurray J, White H, Maggioni A . Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur Heart J. 2009; 30(18):2226-32. DOI: 10.1093/eurheartj/ehp256. View

4.
Tomaselli G, Mahaffey K, Cuker A, Dobesh P, Doherty J, Eikelboom J . 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020; 76(5):594-622. DOI: 10.1016/j.jacc.2020.04.053. View

5.
Smilowitz N, Gupta N, Ramakrishna H, Guo Y, Berger J, Bangalore S . Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery. JAMA Cardiol. 2016; 2(2):181-187. PMC: 5563847. DOI: 10.1001/jamacardio.2016.4792. View